In Practice: Clinical Insights
Novel Psychoactive Substances: Newly Identified Threats Detected in the Second Half of 2022
Date: March 28, 2023
Length: 25 minutes
Novel Psychoactive Substances: What is Xylazine?
Date: January 24, 2023
Length: 15 minutes
InterACT Rx Pharmacodynamic Insights: A Brief Look at QTc Prolongation, Serotonin Syndrome, and Tardive Dyskinesia
Date: October 25, 2022
Length: 20 minutes
Complexities of Risk Assessment: Opioids, Drug Interactions, & Designer Benzodiazepines
Date: September 28, 2022
Length: 17 minutes
Behavioral Health: Why Monitor Patients for Medication Adherence
Date: August 31, 2022
Length: 15 minutes